...
....
Pharmaceutical
Biotechnology

> See specialized channels
Medical Devices & Diagnostics
> See specialized channels
Industrial
Biotechnology
> See specialized channels


  Join us

  Follow us on Twitter   Join our LinkedIn Group   Our Blog

Biotech News App
Provides access to the latest biotech press releases ...more

Android_Logo App Store RIM_Logo_small

Media Partnership:
Want to have your RSS feed integrated on our website? Contact us
RSS Feeds RSS Feeds
JoomlaWatch Stats 1.2.9 by Matej Koval
For Editors
Sign up for press releases
For Companies
Sign up for our newsletter
Back to PRESS RELEASES - 

Haselmeier Announces the Extension of Its Business Development Organization within the Haselmeier Group

| Print |
Friday, 17 January 2014 10:30 (UTC + 1)

Haselmeier Logo

Zurich, Switzerland, January 17, 2014 / B3C newswire / - Haselmeier announced the addition of Terence O’Hagan as Director of Business Development based in the United States. Previously, he was the Senior Director of Business Development at Flextronics Medical Division and Global Director of Strategy and Business Development at Radius Product Development.

Terence O’Hagan has over 10 years of business development and strategy experience in the medical device industry and 15 years with consumer electronics where he held positions in product development, manufacturing, strategic marketing and business unit management. Robert J. Kilgore, President of Haselmeier, Inc. commented “Terry’s extensive knowledge in the areas of product design, development and assembly will enable Haselmeier to continue providing the highest value and service to our customers.”


About Haselmeier
Haselmeier is a leading designer and manufacturer of pen and auto-injection systems. The Company’s devices feature unique function, design and technology and are marketed by leading pharmaceutical and biotechnology companies around the world.

For more information please visit www.haselmeier.com


Contact:

Haselmeier GmbH
Dufourstrasse 32
8008 Zürich
Switzerland

Nadia Di Secli
Tel: + (41) 44 250 58 50
This e-mail address is being protected from spambots. You need JavaScript enabled to view it